{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:36:30Z","timestamp":1783524990518,"version":"3.55.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The impact of systolic blood pressure (SBP) variation on chronic heart failure (HF) is largely unknown. We assessed the impact of SBP variation in patients with chronic HF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective analysis of adult ambulatory patients with HF with left ventricular systolic dysfunction (LVSD). SBP variation = SBP at the index visit \u2013 SBP at the 1-year visit. Patients dying in the first year or with missing data concerning SBP were excluded. Patients with SBP increase \u226510 mmHg during the first year were compared with the remaining. Determinants of SBP increase were assessed by binary logistic regression analysis. The patients were followed up from the 1-year visit up to 5 years. The primary end point was all-cause mortality. A Cox regression analysis was used to determine the association of SBP variation with mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We studied 787 patients (68% male), with a mean age of 70 years. SBP increased by \u226510 mmHg in 277 patients (35.2%) and remained stable or decreased in 510. Patients in whom SBP increased more often presented severe LVSD and nonischemic HF; they had lower baseline SBP and were more medicated with loop diuretics. Independent predictors of SBP increase were lower basal SBP and loop diuretic use. Patients with a SBP increase \u226510 mmHg had a crude hazard ratio (HR) of all-cause mortality of 0.74 (0.59\u20130.94), and the multivariate-adjusted HR was 0.61 (0.46\u20130.79).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Patients with chronic HF with SBP increase \u226510 mmHg over the first year have a 39% reduction in the all-cause mortality risk irrespective of basal SBP, severity of ventricular dysfunction, and evidence-based drug use. Patients with SBP stability or decrease have a similarly poor prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000284","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:02:15Z","timestamp":1742299335000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Systolic blood pressure increase in chronic heart failure associates with survival advantage"],"prefix":"10.1097","volume":"10","author":[{"given":"Helena","family":"Rocha","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gouveia","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Elias","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Reis","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Margarida","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Costa","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Toste","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grij\u00f3","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Reis","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Neves","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Almeida","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Louren\u00e7o","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centro Hospitalar de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Department of Medicine, Faculty of Medicine, Porto University, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3]]},"reference":[{"issue":"38","key":"R1-20250318","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"6","key":"R2-20250318","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"19","key":"R3-20250318","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2017.11.005","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"R4-20250318","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","article-title":"2018 practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC task force for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"issue":"36","key":"R5-20250318","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"R6-20250318","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","article-title":"J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data","volume":"136","author":"Boutitie","year":"2002","journal-title":"Ann Int Med"},{"issue":"1","key":"R7-20250318","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000446922","article-title":"The J-curve phenomenon in hypertension","volume":"4","author":"Kang","year":"2016","journal-title":"Pulse (Basel)"},{"issue":"7","key":"R8-20250318","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/HJH.0b013e32832d7370","article-title":"Prognostic value of blood pressure in patients with high vascular risk in the ongoing telmisartan alone and in combination with Ramipril Global Endpoint Trial study","volume":"27","author":"Sleight","year":"2009","journal-title":"J Hypertens"},{"issue":"24","key":"R9-20250318","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension","volume":"348","author":"Clement","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"R10-20250318","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ejhf.3108","article-title":"Blood pressure levels and adverse cardiovascular outcomes in heart failure: a systematic review and meta-analysis","volume":"26","author":"Seidu","year":"2024","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"R11-20250318","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1875-2136(08)73697-0","article-title":"In-hospital mortality and prognostic factors in patients admitted for new-onset heart failure with preserved or reduced ejection fraction: a prospective observational study","volume":"101","author":"Tribouilloy","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"issue":"18","key":"R12-20250318","doi-asserted-by":"crossref","first-page":"e022288","DOI":"10.1161\/JAHA.121.022288","article-title":"Systolic blood pressure and outcome in patients admitted with acute heart failure: an analysis of individual patient data from 4 randomized clinical trials","volume":"10","author":"Grand","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"R13-20250318","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/hrt.2007.134973","article-title":"Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure","volume":"95","author":"Raphael","year":"2009","journal-title":"Heart"},{"issue":"2","key":"R14-20250318","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.889","article-title":"Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?","volume":"20","author":"Cotter","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"R15-20250318","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jchf.2021.07.001","article-title":"Association of early blood pressure decrease and renal function with prognosis in acute heart failure","volume":"9","author":"Matsue","year":"2021","journal-title":"JACC Heart Fail"},{"key":"R16-20250318","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejim.2024.09.003","article-title":"Association between trajectory of systolic blood pressure and outcomes in heart failure patients with preserved ejection fraction (HFpEF)","volume":"131","author":"Liu","year":"2025","journal-title":"Eur J Int Med"},{"key":"R17-20250318","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2015.03.169","article-title":"Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: insights from the HEAAL study","volume":"187","author":"Rossignol","year":"2015","journal-title":"Int J Cardiol"},{"issue":"7","key":"R18-20250318","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.805","article-title":"Prognostic value of long-term blood pressure changes in patients with chronic heart failure","volume":"19","author":"Schmid","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"R19-20250318","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1002\/ehf2.13542","article-title":"Blood pressure visit-to-visit variability and outcomes in patients with heart failure with preserved ejection fraction","volume":"8","author":"Zhang","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"8","key":"R20-20250318","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"R21-20250318","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"8","key":"R22-20250318","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/eurjhf\/hfr070","article-title":"Impact of changes in blood pressure during the treatment of acute decompensated heart failure on renal and clinical outcomes","volume":"13","author":"Testani","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"R23-20250318","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurjhf\/hfr060","article-title":"Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF","volume":"13","author":"Voors","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"R24-20250318","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/HYPERTENSIONAHA.120.16757","article-title":"Visit-to-Visit blood pressure variability and clinical outcomes in patients with heart failure with preserved ejection fraction","volume":"77","author":"Wei","year":"2021","journal-title":"Hypertension"},{"issue":"2","key":"R25-20250318","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/HYPERTENSIONAHA.110.162255","article-title":"The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994","volume":"57","author":"Muntner","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"R26-20250318","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/M14-2803","article-title":"Visit-to-Visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: a cohort study","volume":"163","author":"Muntner","year":"2015","journal-title":"Ann Int Med"},{"key":"R27-20250318","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40885-016-0051-z","article-title":"Prognostic value of systolic short-term blood pressure variability in systolic heart failure","volume":"22","author":"Berry","year":"2016","journal-title":"Clin Hypertens"},{"issue":"10","key":"R28-20250318","first-page":"955","article-title":"Non-invasive blood pressure variability in chronic heart failure: characteristics and prognostic value","volume":"96","author":"Gibelin","year":"2003","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"12","key":"R29-20250318","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/dom.13828","article-title":"Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: a systematic review and meta-analysis","volume":"21","author":"Chiriaco","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"R30-20250318","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2019.0751","article-title":"Visit-to-Visit blood pressure variability, coronary atheroma progression, and clinical outcomes","volume":"4","author":"Clark","year":"2019","journal-title":"JAMA Cardiol"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T12:02:24Z","timestamp":1742299344000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000284","relation":{},"ISSN":["2444-8672"],"issn-type":[{"value":"2444-8672","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2025-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}